Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis.

A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Abstract Text:

    viktor johansonViktor Johanson, ahlman Ahlman,peter bernhardtPeter Bernhardt,svante janssonSvante Jansson,lars Lars ,fredrik perssonFredrik Persson, stenman Stenman,christina Christina ,bo Bo ,mats stridsbergMats Stridsberg,ola nilssonOla Nilsson,

    Hereditary medullary thyroid carcinoma (MTC) is caused by germline mutations in the RET proto-oncogene, resulting in constitutive activation of the RET tyrosine kinase. A substantial proportion of sporadic MTCs also have RET mutations, making the RET tyrosine kinase a potential therapeutic target in MTC. We have established a transplantable MTC in nude mice from a sporadic human MTC carrying a RET C634R mutation. Transplanted tumors had an exponential growth rate with an approximate doubling time of about 3 weeks, and expressed a neuroendocrine phenotype characteristic of MTC, e.g., expression of calcitonin, chromogranin A (CgA), synaptophysin, synaptic vesicle protein 2 (SV2), vesicular monoamine transporter-1 and -2, carcinoembryonic antigen, cytokeratin 8/18, epithelial cadherin, and neural cell adhesion molecule. Plasma calcitonin and CgA levels were elevated in tumor-bearing mice and correlated with tumor size. Cytogenetic analysis, including spectral karyotyping, confirmed the human origin of the xenografted tumors and demonstrated an abnormal, near triploid karyotype. Treatment of tumor-bearing nude mice with the tyrosine kinase inhibitor ZD6474, which specifically inhibits RET, epidermal growth factor receptor (EGFR), and vascular endothelium growth factor receptor (VEGFR) tyrosine kinases, resulted in a dose-dependent inhibition of tumor growth. Oral ZD6474 given once daily (250 mg/kg, 5 days/week) reduced tumor volume to 11% when compared with controls after 4 weeks. Our results show that this transplantable MTC, designated GOT2, represents a novel and useful model for studies of MTC and RET tyrosine kinase-dependent tumor growth.

    A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Publishing Authors By Initials

    v johansonV Johanson,h ahlmanH Ahlman,p bernhardtP Bernhardt,s janssonS Jansson,l L ,f perssonF Persson,g stenmanG Stenman,c C ,b B ,m stridsbergM Stridsberg,o nilssonO Nilsson,

    For similar xenograft model antitumor assays research abstracts see: xenograft model antitumor assays research

    PUBMED ID PMID:

    MEDLINE DATE:

    A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Endocrine-related cancer

    VOLUME: 14

    Page Numbers: 433-44

    Journal Abbreviation: Endocr. Relat. Cancer

    ISSN: 1351-0088

    DAY: 20

    MONTH: Jun

    YEAR: 2007

    A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9436481

    A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Keywords Mesh Terms:

    KEYWORDS: Xenograft Model Antitumor Assays

    MESH TERMS: antagonists & inhibitors

    Chemical & Substance for Abstract: A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Information

    Substance Name: Vascular Endothelial Growth Factor Recep

    Registry Number: EC 2.7.1.112

    Grant and Affiliation Information for A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis.

    AFFILIATION: Lundberg Laboratory for Cancer Research, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. viktor.johanson@medfak.gu.se

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Endocr Relat Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News